Spinal analgesic activity of orphanin FQ/nociceptin and its fragments Journal Article


Authors: King, M. A.; Rossi, G. C.; Chang, A. H.; Williams, L.; Pasternak, G. W.
Article Title: Spinal analgesic activity of orphanin FQ/nociceptin and its fragments
Abstract: Previous work reveals that orphanin FQ/nociceptin (OFQ/N) administered supraspinally produces an initial hyperalgesic response followed by analgesia. Spinally, OFQ/N elicits a rapidly appearing, naltrexone-reversible, dose-dependent analgesia in the tailflick assay without any indication of hyperalgesia. Two OFQ/N fragments, OFQ/N (1-7) and OFQ/N (1-11), are active, but far weaker. Blockade of sigma receptors with haloperidol enhances the analgesic potency of spinal OFQ/N, OFQ/N (1-7) and OFQ/N (1-11), but not as dramatically as supraspinal OFQ. Antisense probes targeting the second and third coding exons, but not the first exon, of the cloned mouse OFQ/N receptor (KOR-3) partially block OFQ/N analgesia.
Keywords: controlled study; exons; nonhuman; mouse; animals; mice; haloperidol; animal experiment; drug synergism; mice, inbred strains; cloning, molecular; spinal cord; peptide fragments; analgesics; analgesia; hyperalgesia; nociception; tail flick test; opiate receptor; opioid peptides; receptors, sigma; nociceptin; antisense oligodeoxynucleotide; opiate agonist; receptors, opioid; male; priority journal; article; antisense elements (genetics); sigma opiate receptor; orphanin fq; kor-3; orl-1
Journal Title: Neuroscience Letters
Volume: 223
Issue: 2
ISSN: 0304-3940
Publisher: Elsevier Science, Inc.  
Date Published: 1997-02-21
Start Page: 113
End Page: 116
Language: English
DOI: 10.1016/s0304-3940(97)13414-0
PUBMED: 9089686
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 17 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael A King
    24 King
  2. Grace Rossi
    61 Rossi
  3. Gavril W Pasternak
    414 Pasternak
  4. Albert H Chang
    19 Chang